Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4936-4944

  Bucki, Robert ^a   Byfield, Fitzroy J ^a   Kulakowska, Alina ^b   McCormick, Margaret E ^a   Drozdowski, Wieslaw ^b   Namiot, Zbigniew ^b   Hartung, Thomas ^c,d   Janmey, Paul A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c JOINT RESEARCH CENTRE   (Italy)

^d UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; F ACTIN; GELSOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; ACTIN; AUTACOID; GELSOLIN (160 169); GELSOLIN (160-169); PEPTIDE FRAGMENT; TEICHOIC ACID; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIGEN RECOGNITION; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL OUTER MEMBRANE; BILE; BINDING AFFINITY; BINDING SITE; BLOOD; CELL ADHESION; CELL DIVISION; CELL FUNCTION; CEREBROSPINAL FLUID; CYTOKINE RELEASE; DEPOLYMERIZATION; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SALIVA; BIOSYNTHESIS; CELL CULTURE; CELL WALL; CELLULAR IMMUNITY; CYTOLOGY; DRUG ANTAGONISM; EXTRACELLULAR FLUID; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PROTEIN BINDING; SECRETION; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

ACTINS; CELL ADHESION; CELL WALL; CELLS, CULTURED; E-SELECTIN; EXTRACELLULAR FLUID; GELSOLIN; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NEUTROPHILS; NF-KAPPA B; PEPTIDE FRAGMENTS; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 57849150175     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4936     Document Type: Article

References (59)

1. Yin, H. L., and T. P. Stossel. 1979. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 281: 583-586.
2. Kwiatkowski, D. J. 1999. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11: 103-108.
3. Witke, W., A. H. Sharpe, J. H. Hartwig, T. Azuma, T. P. Stossel, and D. J. Kwiatkowski. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81: 41-51.
4. Lind, S. E., D. B. Smith, P. A. Janmey, and T. P. Stossel. 1988. Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am. Rev. Respir. Dis. 138: 429-434.
5. Rothenbach, P. A., B. Dahl, J. J. Schwartz, G. E. O'Keefe, M. Yamamoto, W. M. Lee, J. W. Horton, H. L. Yin, and R. H. Turnage. 2004. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J. Appl. Physiol. 96: 25-31.
6. Smith, D. B., P. A. Janmey, and S. E. Lind. 1988. Circulating actin-gelsolin complexes following oleic acid-induced lung injury. Am. J. Pathol. 130: 261-267. (Pubitemid 18076360)
7. Smith, D. B., P. A. Janmey, J. A. Sherwood, R. J. Howard, and S. E. Lind. 1988. Decreased plasma gelsolin levels in patients with Plasmodium falciparum malaria: a consequence of hemolysis? Blood 72: 214-218.
8. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
9. Christofidou-Solomidou, M., A. Scherpereel, C. C. Solomides, J. D. Christie, T. P. Stossel, S. Goelz, and M. J. DiNubile. 2002. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J. Investig. Med. 50: 54-60. (Pubitemid 34098289)
10. Suhler, E., W. Lin, H. L. Yin, and W. M. Lee. 1997. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit. Care Med. 25: 594-598. (Pubitemid 27193970)
11. Dahl, B., F. V. Schiodt, P. Ott, R. Gvozdenovic, H. L. Yin, and W. M. Lee. 1999. Plasma gelsolin is reduced in trauma patients. Shock 12: 102-104.
12. Mounzer, K. C., M. Moncure, Y. R. Smith, and M. J. Dinubile. 1999. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am. J. Respir. Crit. Care Med. 160: 1673-1681.
13. Goetzl, E. J., H. Lee, T. Azuma, T. P. Stossel, C. W. Turck, and J. S. Karliner. 2000. Gelsolin binding and cellular presentation of lysophosphatidic acid. J. Biol. Chem. 275: 14573-14578. (Pubitemid 30339747)
14. Bucki, R., P. C. Georges, Q. Espinassous, M. Funaki, J. J. Pastore, R. Chaby, and P. A. Janmey. 2005. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44: 9590-9597. (Pubitemid 40994353)
15. Mintzer, E., H. Sargsyan, and R. Bittman. 2006. Lysophosphatidic acid and lipopolysaccharide bind to the PIP2-binding domain of gelsolin. Biochim. Biophys. Acta 1758: 85-89.
16. Lee, H., E. J. Goetzl, and S. An. 2000. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am. J. Physiol. 278: C612-C618.
17. Osborn, T. M., C. Dahlgren, J. H. Hartwig, and T. P. Stossel. 2007. Modifications of cellular responses to lysophosphatidic acid (LPA) and platelet activating factor (PAF) by plasma gelsolin (pGSN). Am. J. Physiol. 292: C1323-C1331.
18. Schneider, O., U. Michel, G. Zysk, O. Dubuis, and R. Nau. 1999. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology 53: 1584-1587. (Pubitemid 29491960)
19. Lotz, S., E. Aga, I. Wilde, G. van Zandbergen, T. Hartung, W. Solbach, and T. Laskay. 2004. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukocyte Biol. 75: 467-477. (Pubitemid 38316378)
20. Erridge, C., E. Bennett-Guerrero, and I. R. Poxton. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4: 837-851.
21. Tohme, Z. N., S. Amar, and T. E. Van Dyke. 1999. Moesin functions as a lipopolysaccharide receptor on human monocytes. Infect. Immun. 67: 3215-3220.
22. Brandenburg, K., J. Andra, M. Muller, M. H. Koch, and P. Garidel. 2003. Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr. Res. 338: 2477-2489. (Pubitemid 37509948)
23. Hermann, C., I. Spreitzer, N. W. Schroder, S. Morath, M. D. Lehner, W. Fischer, C. Schutt, R. R. Schumann, and T. Hartung. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species: role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-γ release. Eur. J. Immunol. 32: 541-551. (Pubitemid 34173345)
24. Kawai, T., and S. Akira. 2007. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13: 460-470
25. Kao, S. J., H. C. Lei, C. T. Kuo, M. S. Chang, B. C. Chen, Y. C. Chang, W. T. Chiu, and C. H. Lin. 2005. Lipoteichoic acid induces nuclear factor-κB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115: 366-374.
26. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Tolllike receptor 2. J. Biol. Chem. 274: 17406-17409. (Pubitemid 129519082)
27. Schroder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587-15594.
28. Grandel, U., M. Hopf, M. Buerke, K. Hattar, M. Heep, L. Fink, R. M. Bohle, S. Morath, T. Hartung, et al. 2005. Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts. Circulation 112: 691-698. (Pubitemid 41099048)
29. Boveri, M., A. Kinsner, V. Berezowski, A. M. Lenfant, C. Draing, R. Cecchelli, M. P. Dehouck, T. Hartung, P. Prieto, and A. Bal-Price. 2006. Highly purified lipoteichoic acid from Gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 137: 1193-1209. (Pubitemid 43133145)
30. Cunningham, C. C., R. Vegners, R. Bucki, M. Funaki, N. Korde, J. H. Hartwig, T. P. Stossel, and P. A. Janmey. 2001. Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly. J. Biol. Chem. 276: 43390-43399. (Pubitemid 37371029)
31. Ellingsen, E., S. Morath, T. Flo, A. Schromm, T. Hartung, C. Thiemermann, T. Espevik, D. Golenbock, D. Foster, R. Solberg, et al. 2002. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 8: BR149-BR153.
32. Spudich, J. A., and S. Watt. 1971. The regulation of rabbit skeletal muscle contraction: I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J. Biol. Chem. 246: 4866-4871.
33. Burtnick, L. D., E. K. Koepf, J. Grimes, E. Y. Jones, D. I. Stuart, P. J. McLaughlin, and R. C. Robinson. 1997. The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell 90: 661-670.
34. Bucki, R., P. A. Janmey, R. Vegners, F. Giraud, and J. C. Sulpice. 2001. Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets: use of a permeant phosphoinositide-binding peptide. Biochemistry 40: 15752-15761. (Pubitemid 34015204)
35. Janmey, P. A., and S. E. Lind. 1987. Capacity of human serum to depolymerize actin filaments. Blood 70: 524-530. (Pubitemid 17142939)
36. Blease, K., Y. Chen, P. G. Hellewell, and A. Burke-Gaffney. 1999. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells. J. Immunol. 163: 6139-6147. (Pubitemid 128772013)
37. Bucki, R., and P. A. Janmey. 2006. Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Antimicrob. Agents Chemother. 50: 2932-2940. (Pubitemid 44403774)
38. Giacometti, A., O. Cirioni, G. Greganti, M. Quarta, and G. Scalise. 1998. In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 42: 3320-3324. (Pubitemid 28553766)
39. Santos, N. C., A. C. Silva, M. A. Castanho, J. Martins-Silva, and C. Saldanha. 2003. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 4: 96-100. (Pubitemid 36114216)
40. Bucki, R., and J. J. Pastore. 2006. Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin. Eur. J. Haematol. 76: 510-515.
41. Coue, M., J. Constans, M. Viau, and A. Olomucki. 1983. The effect of serum vitamin D-binding protein on polymerization and depolymerization of actin is similar to the effect of profilin on actin. Biochim. Biophys. Acta 759: 137-145.
42. Kawamura, N., N. Imanishi, H. Koike, H. Nakahara, L. Phillips, and S. Morooka. 1995. Lipoteichoic acid-induced neutrophil adhesion via E-selectin to human umbilical vein endothelial cells (HUVECs). Biochem. Biophys. Res. Commun. 217: 1208-1215. (Pubitemid 26019780)
43. Risco, C., J. L. Carrascosa, and M. A. Bosch. 1993. Visualization of lipopolysaccharide aggregates by freeze-fracture and negative staining. J. Electron Microsc. 42: 202-204.
44. Risco, C., J. E. Dominguez, M. A. Bosch, and J. L. Carrascosa. 1993. Biochemical and electron microscopy analysis of the endotoxin binding to microtubules in vitro. Mol. Cell. Biochem. 121: 67-74. (Pubitemid 23133933)
45. Takeuchi, O., and S. Akira. 2001. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1: 625-635. (Pubitemid 32206524)
46. Card, G. L., R. R. Jasuja, and G. L. Gustafson. 1994. Activation of arachidonic acid metabolism in mouse macrophages by bacterial amphiphiles. J. Leukocyte Biol. 56: 723-728.
47. Janmey, P. A., and T. P. Stossel. 1989. Gelsolin-polyphosphoinositide interaction: full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group. J. Biol. Chem. 264: 4825-4831.
48. Meerschaert, K., V. De Corte, Y. De Ville, J. Vandekerckhove, and J. Gettemans. 1998. Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J. 17: 5923-5932. (Pubitemid 28474787)
49. Bas, S., B. R. Gauthier, U. Spenato, S. Stingelin, and C. Gabay. 2004. CD14 is an acute-phase protein. J. Immunol. 172: 4470-4479.
50. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a lipopolysaccharide- binding acute phase reactant from rabbit serum. J. Exp. Med. 164: 777-793.
51. Christofidou-Solomidou, M., A. Scherpereel, C. C. Solomides, V. R. Muzykantov, M. Machtay, S. M. Albelda, and M. J. DiNubile. 2002. Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 180: 91-104. (Pubitemid 35477918)
52. Lee, P. S., A. B. Waxman, K. L. Cotich, S. W. Chung, M. A. Perrella, and T. P. Stossel. 2007. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit. Care Med. 35: 849-855.
53. Yuan, X., and D. M. Desiderio. 2003. Proteomics analysis of phosphotyrosylproteins in human lumbar cerebrospinal fluid. J. Proteome Res. 2: 476-487. (Pubitemid 37376842)
54. Kulakowska, A., W. Drozdowski, A. Sadzynski, R. Bucki, and P. A. Janmey. 2008. Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders. Eur. J. Neurol. 15: 584-588. (Pubitemid 351677512)
55. Kinsner, A., V. Pilotto, S. Deininger, G. C. Brown, S. Coecke, T. Hartung, and A. Bal-Price. 2005. Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation. J. Neurochem. 95: 1132-1143. (Pubitemid 41713496)
56. Jiang-Shieh, Y. F., K. Y. Yeh, I. H. Wei, C. Y. Chang, H. F. Chien, R. Y. Tsai, M. L. Chang, A. W. Lee, M. H. Pai, and C. H. Wu. 2005. Responses of microglia in vitro to the Gram-positive bacterial component, lipoteichoic acid. J. Neurosci. Res. 82: 515-524.
57. Bucki, R., I. Levental, and P. A. Janmey. 2007. Antibacterial peptides: a bright future or a false hope. Anti-Infective Agents Med. Chem. 6: 175-184. (Pubitemid 47099055)
58. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891.
59. Gutsmann, T., S. O. Hagge, J. W. Larrick, U. Seydel, and A. Wiese. 2001. Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys. J. 80: 2935-2945. (Pubitemid 32521665)